Patents Examined by Jeffrey Siew
  • Patent number: 6821771
    Abstract: The present invention concerns a device for amplifying target nucleic acids, reaction cartridge s for use in the device, and modes of use of the device.
    Type: Grant
    Filed: October 15, 2001
    Date of Patent: November 23, 2004
    Assignee: Genesystems
    Inventor: Gabriel Festoc
  • Patent number: 6811980
    Abstract: The present invention relates to a process for immobilization of nucleic acid molecules on a substrate, wherein the substrate is treated with atomic oxygen plasma prior to immobilizing the nucleic acid molecules thereon. The invention is further related to immobilized nucleic acid molecules and uses thereof.
    Type: Grant
    Filed: November 19, 2001
    Date of Patent: November 2, 2004
    Assignee: Sony International (Europe) GmbH
    Inventors: William E. Ford, Jurina Wessels, Oliver Harnack
  • Patent number: 6808873
    Abstract: The invention provides methods for screening for agents that modulate mitochondrial function and in particular mitochondrial regulation of intracellular calcium. The methods may be used to detect agents that bind to a mitochondrial calcium uniporter and may also detect inhibitors or uncouplers of mitochondrial respiration. Agents identified using the screens provided herein have application in the prevention and treatment of a variety of diseases associated with abnormal mitochondrial function.
    Type: Grant
    Filed: January 16, 2001
    Date of Patent: October 26, 2004
    Assignee: MitoKor, Inc.
    Inventors: Anne N. Murphy, Amy K. Stout
  • Patent number: 6806051
    Abstract: Partially nonhybridizing oligonucleotides are provided that contain two or more hybridizing segments, with any two hybridizing segments separated by a nonhybridizing spacer segment, i.e., a nucleotidic or nonnucleotidic segment that has little or no likelihood of binding to an oligonucleotide sequence found in nature. Oligonucleotide arrays are also provided in which at least one of the oligonucleotides of the array is a partially nonhybridizing oligonucleotide. The partially nonhybridizing oligonucleotides serve as multifunctional probes wherein each hybridizing segment of a single partially nonhybridizing oligonucleotide serves as an individual probe. Also provided are methods for preparing and using the partially nonhybridizing oligonucleotides and arrays formed therewith. A particularly preferred method of array fabrication involves the use of focused acoustic energy.
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: October 19, 2004
    Assignee: Picoliter Inc.
    Inventor: Richard N. Ellson
  • Patent number: 6803229
    Abstract: The present invention relates to a procedure for the qualitative and/or quantitative analysis of biological substances, which are preferably biological substances, that are present in a conductive liquid medium, with the aid of at least one affinity sensor that includes at least one structure that includes at least one semiconductor material, which is coated on one of its surface with at least one layer of an isolating material, which in turn is affixed adhesively to at least one sensitive membrane, which is in contact with the conductive medium and which includes ligands that are complementary to the biological substances in question and which are capable of, and suitable for, forming pairs specifically with the latter biological substances, with the said procedure being characterized by the fact that it consists essentially of applying a voltage between the semiconductor and the conductive medium; of gathering the variations in the electrical signals induced by a charge-effect phenomenon directly and essent
    Type: Grant
    Filed: March 25, 2003
    Date of Patent: October 12, 2004
    Assignees: L'Ecole Centrale de Lyon, Le Centre National de la Recherche Scientifique
    Inventors: Jean-Rene Martin, Eliane Souteyrand, Marcus Francois Lawrence, Susan Rosalie Mikkelsen
  • Patent number: 6803228
    Abstract: The present invention relates to a method to produce a biochip and to a biochip, said biochip being composed particularly of biological probes grafted onto a conductive polymer. The method according to the invention comprises the following steps: a) structuring of a substrate so as to obtain on said substrate microtroughs comprising in their base a layer of a material capable of initiating and promoting the adhesion onto said layer of a film of a pyrrole and functionalised pyrrole copolymer by electropolymerisation, b) collective electropolymerisation, so as to form an electropolymerised film of a pyrrole and functionalised pyrrole copolymer on the base of said microtroughs, c) direct or indirect fixation of functionalised oligonucleotides by microdeposition or a liquid jet printing technique.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: October 12, 2004
    Assignee: Commissariart A L'Energie Atomique
    Inventors: Patrice Caillat, Charles Rosilio
  • Patent number: 6800438
    Abstract: An improved method for the sequencing of DNA fragments is provided. The method includes using a known process for DNA fragment separation, such as capillary electrophoresis, and imaging the resultant gel plate with a full-width array scanner or a two-dimensional amorphous silicon image sensor array. The DNA sample is placed within a well of the separation apparatus, such as a capillary tube or plurality thereof. The separation apparatus is then placed in a buffer. An electric field is then applied, forming a bias between the ends along which the sample is separated. Once separated, the large area detector scans the entire gel plate and resultant image data is provided. By way of the improved method, the entire gel plate can be scanned at the same time and repeatedly, resulting in greater accuracy and a shorter time to sequence.
    Type: Grant
    Filed: December 28, 2000
    Date of Patent: October 5, 2004
    Assignee: Xerox Corporation
    Inventors: Jaan Noolandi, Robert A. Street, Neville Connell
  • Patent number: 6797469
    Abstract: Methods are provided for depositing a quantity of fluid onto the surface of an array. In the subject methods, a thermal inkjet head loaded with the fluid is positioned in opposing relationship to, e.g. over, the array surface. Actuation of the thermal inkjet results in the expulsion of a quantity of fluid onto the array surface. The subject methods find particular use in array-based binding assays in which an array of binding agents is employed for the detection of an analyte(s), particularly array-based hybridization assays.
    Type: Grant
    Filed: March 26, 2001
    Date of Patent: September 28, 2004
    Assignee: Agilent Technologies, Inc.
    Inventors: Michael P. Caren, Kevin J. Luebke
  • Patent number: 6794498
    Abstract: A method of locating an inhibitory/instability sequence or sequences within the coding region of an mRNA and modifying the gene encoding that mRNA to remove these inhibitory/instability sequences by making clustered nucleotide substitutions without altering the coding capacity of the gene is disclosed. Constructs containing these mutated genes and host cells containing these constructs are also disclosed. The method and constructs are exemplified by the mutation of a Human Immunodeficiency Virus-1 Rev-dependent gag gene to a Rev-independent gag gene. Constructs useful in locating inhibitory/instability sequences within either the coding region or the 3′ untranslated region of an mRNA are also disclosed. The exemplified constructs of the invention may also be useful in HIV-1 immunotherapy and immunoprophylaxis.
    Type: Grant
    Filed: August 31, 2001
    Date of Patent: September 21, 2004
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: George N. Pavlakis, Barbara K. Felber
  • Patent number: 6794138
    Abstract: The present invention relates to the amplification of nucleic acids, preferably from mRNA. A primer and promoter are added to a target sequence to be amplified and then the target is amplified in an in vitro transcription reaction and the product of this reaction is used as template for subsequent rounds of amplification.
    Type: Grant
    Filed: September 24, 2001
    Date of Patent: September 21, 2004
    Assignee: Affymetrix, Inc.
    Inventors: Yanxiang Cao, Linda Hsie
  • Patent number: 6790651
    Abstract: According to the present invention, hybridization reaction and washing steps can be carried out continuously without taking out the substrate from the apparatus, thereby simplifying manipulation of the experiment. A reaction solution or a washing solution is injected with a pump 6 and discharged with a pump 22 into and from a case 3 which accommodates a substrate 1 immobilized with biological substances. As the substrate 1, a disc-shaped substrate with a throughhole at the center is used. An agitator 2 is placed in the throughhole to agitate the reaction solution or the washing solution during the hybridization reaction or the subsequent washing, thereby shortening the reaction time and the washing time.
    Type: Grant
    Filed: December 11, 2001
    Date of Patent: September 14, 2004
    Assignee: Hitachi Software Engineering Co., Ltd.
    Inventors: Toshiaki Tanaka, Mitsuhiro Tachibana, Shigeru Kijima
  • Patent number: 6783940
    Abstract: The invention provides methods for reducing non-specific amplification DNA in a polymerase chain reaction comprising providing a sample comprising a target DNA sequence of interest; contacting the sample with at least one enzyme having nucleic acid polymerase activity; and incubating the sample with said enzyme for a time and under conditions sufficient to amplify the target DNA sequence, forming amplified target sequence; wherein the incubation is performed in the presence of an amount of sorbitol, or sorbitol and DMSO effective to reduce the non-specific amplification relative to the amount of non-specific amplification observed in the absence of sorbitol, or sorbitol and DMSO. The methods are suitable for amplification of ribosomal DNA, particularly from clinical samples. Compositions and kits containing sorbitol, or sorbitol and DMSO for reducing non-specific amplification are also provided.
    Type: Grant
    Filed: October 31, 2001
    Date of Patent: August 31, 2004
    Assignee: Applera Corporation
    Inventors: Ian J. McLaughlin, Sulekha Rao Coticone, Will Bloch
  • Patent number: 6783931
    Abstract: Nucleosides and oligonucleosides functionalized to include alkylamino functionality, and derivatives thereof. In certain embodiments, the compounds of the invention further include steriods, reporter molecules, reporter enzymes, lipophilic molecules, peptides or proteins attached to the nucleosided through the alkylamino group.
    Type: Grant
    Filed: September 3, 1993
    Date of Patent: August 31, 2004
    Assignee: ISIS Pharmaceuticals, Inc.
    Inventors: Phillip Dan Cook, Muthiah Manoharan, Charles J. Guinosso
  • Patent number: 6780584
    Abstract: This invention pertains to the design, fabrication, and uses of an electronic system which can actively carry out and control multi-step and multiplex reactions in macroscopic or microscopic formats. In particular, these reactions include molecular biological reactions, such as nucleic acid hybridizations, nucleic acid amplification, sample preparation, antibody/antigen reactions, clinical diagnostics, combinatorial chemistry and selection, drug screening, oligonucleotide and nucleic acid synthesis, peptide synthesis, biopolymer synthesis and catalytic reactions. A key feature of the present invention is the ability to control the localized concentration of two or more reaction-dependant molecules and their reaction environment in order to greatly enhance the rate and specificity of the molecular biological reaction.
    Type: Grant
    Filed: September 27, 2000
    Date of Patent: August 24, 2004
    Assignee: Nanogen, Inc.
    Inventors: Carl F. Edman, Eugene Tu, Christian Gurtner, Lorelei Westin, Michael J. Heller
  • Patent number: 6777184
    Abstract: Methods, systems and assays are provided for FP detection of nucleic acid hybridization.
    Type: Grant
    Filed: May 11, 2001
    Date of Patent: August 17, 2004
    Assignee: Caliper Life Sciences, Inc.
    Inventors: Theo T. Nikiforov, Sang Jeong
  • Patent number: 6777544
    Abstract: The present invention relates to PNA derivatives which carry, at the N terminus of the PNA backbone, a phosphoryl radical. The phosphoryl radical can be, for example, a phosphate radical, or a substituted phosphoryl radical, with substituted phosphoryl derivatives carrying, where appropriate, one or more labeling groups, groups for crosslinking, groups which promote intracellular uptake, or groups which increase the binding affinity of the PNA derivative for nucleic acids. The invention furthermore relates to a process for preparing the abovementioned PNA derivatives and to their use as pharmaceuticals and diagnostic agents.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: August 17, 2004
    Assignee: Aventis Pharma Deutschland GmbH
    Inventors: Eugen Uhlmann, Gerhard Breipohl, David William Will
  • Patent number: 6777187
    Abstract: Improved methods and reagents for chromosome walking of nucleic acid are discussed herein. A library of amplifiable nick translation molecules is generated, and a chromosome walk is initiated from a known sequence in the nucleic acid by producing at least one nick translate molecule, sequencing part of the nick translate molecule, and producing a second nick translate molecule by initiating the primer extension from the region of the obtained sequence of the prior nick translate molecule.
    Type: Grant
    Filed: November 15, 2001
    Date of Patent: August 17, 2004
    Assignee: Rubicon Genomics, Inc.
    Inventors: Vladimir L. Makarov, Emmanuel Kamberov, Irina Sleptsova
  • Patent number: 6777180
    Abstract: The present invention provides a method for isolating a double-stranded cDNA having a nucleotide sequence of a complete open reading frame which comprises: (A) admixing (i) an isolated single-stranded cDNA, (ii) a first primer capable of forming a stem-loop structure, comprising (a) at the 3′ end of the primer, a first random sequence, linked to (b) a second sequence, linked to (c) a third sequence which forms a loop structure, linked to (d) a fourth sequence, at the 5′ end of the first primer, which is complementary to the second sequence, under hybridization conditions sufficient for annealing the first sequence of the first primer to the sequence at the 3′ end of the single-stranded cDNA, and (iii) a polymerase; (B) incubating the mixture from step (A) under suitable conditions for DNA synthesis; and (C) performing a polymerase chain reaction by admixing (i) an aliquot of the mixture from (B), (ii) a second primer which specifically binds to the single-stranded cDNA, (iii) a third primer
    Type: Grant
    Filed: November 28, 2000
    Date of Patent: August 17, 2004
    Assignee: Trustees of Columbia University in the City of New York
    Inventors: Paul B. Fisher, Dong-Chul Kang
  • Patent number: 6767706
    Abstract: The invention relates to a microfabricated device for the rapid detection of DNA, proteins or other molecules associated with a particular disease. The devices and methods of the invention can be used for the simultaneous diagnosis of multiple diseases by detecting molecules (e.g. amounts of molecules), such as polynucleotides (e.g., DNA) or proteins (e.g., antibodies), by measuring the signal of a detectable reporter associated with hybridized polynucleotides or antigen/antibody complex. In the microfabricated device according to the invention, detection of the presence of molecules (i.e., polynucleotides, proteins, or antigen/antibody complexes) are correlated to a hybridization signal from an optically-detectable (e.g. fluorescent) reporter associated with the bound molecules. These hybridization signals can be detected by any suitable means, for example optical, and can be stored for example in a computer as a representation of the presence of a particular gene.
    Type: Grant
    Filed: June 5, 2001
    Date of Patent: July 27, 2004
    Assignee: California Institute of Technology
    Inventors: Stephen R. Quake, Hou-Pu Chou
  • Patent number: 6767724
    Abstract: The present invention is directed to compositions and methods useful for the amplification of nucleic acid molecules by reverse transcriptase-polymerase chain reaction (RT-PCR). Specifically, the invention provides compositions and methods for the amplification of nucleic acid molecules in a simplified one- or two-step RT-PCR procedure using combinations of reverse transcriptase and thermostable DNA polymerase enzymes in conjunction with sulfur-containing molecules or acetate-containing molecules (or combinations of such sulfur-containing molecules and acetate-containing molecules), and optionally bovine serum albumin. The invention thus facilitates the rapid and efficient amplification of nucleic acid molecules and the detection and quantitation of RNA molecules. The invention also is useful in the rapid production and amplification of cDNAs which may be used for a variety of industrial, medical and forensic purposes.
    Type: Grant
    Filed: August 21, 2002
    Date of Patent: July 27, 2004
    Assignee: Invitrogen Corporation
    Inventors: Jun E. Lee, Ayoub Rashtchian